Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program.
about
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection MethodsThe Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital systemIn vivo efficacy of humanized exposures of Ceftazidime-Avibactam in comparison with Ceftazidime against contemporary Enterobacteriaceae isolates.Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeEvaluation of Remel Spectra CRE Agar for Detection of Carbapenem-Resistant Bacteria from Rectal Swabs Obtained from Residents of a Long-Term-Care Facility.Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates.Carbapenem-Resistant Enterobacteriaceae Infections in Children.Community-Onset Bloodstream and Other Infections, Caused by Carbapenemase-Producing Enterobacteriaceae: Epidemiological, Microbiological, and Clinical Features.Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection.Carbapenem-Resistant Klebsiella pneumoniae Infection in Three New York City Hospitals Trended Downwards From 2006 to 2014.Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and ResisMulticenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.Implications of direct amplification for measuring antimicrobial resistance using point-of-care devices.Carbapenem Nonsusceptible Klebsiella pneumoniae in Taiwan: Dissemination and Increasing Resistance of Carbapenemase Producers During 2012-2015.
P2860
Q26744583-4AEEA8C2-8AEF-4E95-B25B-4648F13A60E1Q30234957-9CB3B8EE-8B20-465C-B907-C499380FAC26Q34183819-E5E19CF9-A4E3-43F7-A7AE-D02622D07770Q34596516-FDEC0DA9-6AB2-4EA9-BF88-4EDD46307D65Q35607885-75040C16-04D3-4CE6-A5DB-65A068A476FEQ35780609-F2735AA0-0812-4AE4-82B2-871B4087EDF0Q35861216-61577C51-C222-4CC2-9A6C-490973C439B2Q35968659-B94BB94E-3395-48C4-9E37-0E0A5FB3413DQ37120191-8EF52B31-A16A-48D4-A25D-C817818FF913Q37154718-B543A06F-7B18-4728-BEEF-91D826161960Q37305509-FDDC53B7-2F1F-463A-B17B-F26A502A97A1Q37374197-3B4148FF-0CED-4994-AFC1-2D90E69A7C23Q37484822-6B4ACE5B-5A8B-463D-9FE6-5B10173EA96AQ38325959-9D77A44F-1021-4FD6-AA60-F0425091C6B1Q40276518-316D7D07-061C-465C-9B1C-3DFA779CD57FQ40342728-6596E70A-66D6-4515-84BA-AF48518BD8E5Q41991759-39C71C3B-4FA1-4DAE-9130-660222D3B207Q42199910-990693BD-C146-48B4-A16A-752AF88CFF3FQ47218332-AF48B338-F5B2-4BE0-91C6-52BB59E7BDEDQ53728436-076C3B1F-9043-4F2D-994F-2FE1B523120EQ53749612-8EAC1C02-5CDD-472A-AEA2-0F6D14A9AFBAQ55088909-9C78EC12-B921-44DC-AFE0-6298161FFFA2
P2860
Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Trends in Klebsiella pneumonia ...... icrobial Surveillance Program.
@en
Trends in Klebsiella pneumonia ...... icrobial Surveillance Program.
@nl
type
label
Trends in Klebsiella pneumonia ...... icrobial Surveillance Program.
@en
Trends in Klebsiella pneumonia ...... icrobial Surveillance Program.
@nl
prefLabel
Trends in Klebsiella pneumonia ...... icrobial Surveillance Program.
@en
Trends in Klebsiella pneumonia ...... icrobial Surveillance Program.
@nl
P2093
P1476
Trends in Klebsiella pneumonia ...... icrobial Surveillance Program.
@en
P2093
Fred Tenover
Robyn M Kaiser
Ronald N Jones
P304
P356
10.1016/J.DIAGMICROBIO.2013.03.032
P577
2013-05-06T00:00:00Z